Sarcomas and DDR-Inhibition; a neoadjuvant phase I combined modality study - SADDRIN-1

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514907-32-00

Acronym

M21SAD

Enrollment

Registered

2024-10-24

Start date

2022-01-21

Completion date

2025-12-09

Last updated

2024-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-metastatic soft tissue sarcoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026